← SynDRA

MUBRITINIB

SynDRA canonical compound SYN0025685 — structure-anchored drug synonym record

All known targets

• ERBB2
• EGFR

Mechanisms of action (all sources)

• ERBB2 INHIBITOR
• Receptor protein-tyrosine kinase erbB-2 inhibitor
• tyrosine kinase inhibitor
• EGFR INHIBITOR

Cross-references

• PubChem CID: 6444692
• ChEMBL: CHEMBL1614707
• DrugBank: DB12682
• ChEBI: 233310
• KEGG: D04025
• Wikipedia: Mubritinib
• TTD: D0A9OV

Synonyms

• TAK-165
• TAK165
• TAK 165
• Mubritinib (USAN/INN)
• 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole
• Mubritinib (TAK 165)
• (E)-4-((4-(4-(1H-1,2,3-triazol-1-yl)butyl)phenoxy)methyl)-2-(4-(trifluoromethyl)styryl)oxazole
• V734AZP9BR
• 1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
• 1-(4-(4-((2-((E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)oxazol-4-yl)methoxy)phenyl)butyl)-1H-1,2,3-triazole
• 1H-1,2,3-triazole, 1-(4-(4-((2-((1E)-2-(4-(trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-
• Mubritinib [USAN]
• Mubritinib [USAN:INN]
• UNII-V734AZP9BR
• (E)-4-[[4-[4-(1H-1,2,3-Triazol-1-yl)butyl]phenoxy]methyl]-2-[4-(trifluoromethyl)styryl]oxazole
• 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole
• 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
• 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
• 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
• Mubritinib;TAK-165
• Mubritinib; TAK-165
• MUBRITINIB [INN]
• Mubritinib - TAK 165
• SCHEMBL94943
• MUBRITINIB, FREE BASE
• MLS006010161
• GTPL6011
• CHEMBL1614707
• Mubritinib, >=98% (HPLC)
• DTXSID501026014
• HMS3414A21
• HMS3678A21
• BCP02837
• EX-A2107
• MFCD09954135
• NSC800802
• s2216
• ZINC11679877
• AKOS015918001